161 related articles for article (PubMed ID: 20158477)
21. Cooperative activation of Src family kinases by SH3 and SH2 ligands.
Yadav SS; Miller WT
Cancer Lett; 2007 Nov; 257(1):116-23. PubMed ID: 17719722
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
23. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
24. Src protein-tyrosine kinase structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
[TBL] [Abstract][Full Text] [Related]
25. The SH2 domain: versatile signaling module and pharmaceutical target.
Machida K; Mayer BJ
Biochim Biophys Acta; 2005 Feb; 1747(1):1-25. PubMed ID: 15680235
[TBL] [Abstract][Full Text] [Related]
26. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
28. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases.
Banin S; Truong O; Katz DR; Waterfield MD; Brickell PM; Gout I
Curr Biol; 1996 Aug; 6(8):981-8. PubMed ID: 8805332
[TBL] [Abstract][Full Text] [Related]
29. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
30. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
[TBL] [Abstract][Full Text] [Related]
31. Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains.
Sperl B; Seifert MH; Berg T
Bioorg Med Chem Lett; 2009 Jun; 19(12):3305-9. PubMed ID: 19427202
[TBL] [Abstract][Full Text] [Related]
32. Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules.
Takemoto Y; Sato M; Furuta M; Hashimoto Y
Int Immunol; 1996 Nov; 8(11):1699-705. PubMed ID: 8943564
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of Src family kinases and therapeutic implications of their modulators.
Kumar A; Jaggi AS; Singh N
Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
Meng Y; Pond MP; Roux B
Acc Chem Res; 2017 May; 50(5):1193-1201. PubMed ID: 28426203
[TBL] [Abstract][Full Text] [Related]
35. Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.
Teli G; Pal R; Maji L; Sengupta S; Raghavendra NM; Matada GSP
Chem Biodivers; 2023 Sep; 20(9):e202300515. PubMed ID: 37563848
[TBL] [Abstract][Full Text] [Related]
36. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
37. Src family kinases: regulation of their activities, levels and identification of new pathways.
Ingley E
Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
[TBL] [Abstract][Full Text] [Related]
38. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase.
Dombrosky-Ferlan PM; Corey SJ
Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881
[TBL] [Abstract][Full Text] [Related]
39. The evolutionarily conserved arrangement of domains in SRC family kinases is important for substrate recognition.
Yadav SS; Miller WT
Biochemistry; 2008 Oct; 47(41):10871-80. PubMed ID: 18803405
[TBL] [Abstract][Full Text] [Related]
40. The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists.
Ijaz M; Wang F; Shahbaz M; Jiang W; Fathy AH; Nesa EU
Protein Pept Lett; 2018 Feb; 24(12):1084-1095. PubMed ID: 29173143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
